HY-B1691-250mg
|
MedChemexpress LLC
|
Methenamine (hippurate) [CAS 5714-73-8]
|
|
Cancer-programmed cell death
|
|
HY-B1691-1mL
|
MedChemexpress LLC
|
Methenamine (hippurate) [CAS 5714-73-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-U00035-10mg
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6]
|
|
COVID-19-immunoregulation
|
|
HY-U00035-100mg
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6]
|
|
COVID-19-immunoregulation
|
|
HY-U00035-25mg
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6]
|
|
COVID-19-immunoregulation
|
|
HY-U00035-5mg
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6]
|
|
COVID-19-immunoregulation
|
|
HY-U00035-50mg
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6]
|
|
COVID-19-immunoregulation
|
|
HY-U00035-1mL
|
MedChemexpress LLC
|
MGB-BP-3 [CAS 1000277-08-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-125728-1mg
|
MedChemexpress LLC
|
Micrococcin P1 [CAS 67401-56-3]
|
|
COVID-19-anti-virus
|
|
HY-125728-500ug
|
MedChemexpress LLC
|
Micrococcin P1 [CAS 67401-56-3]
|
|
COVID-19-anti-virus
|
|
HY-12689-10mg
|
MedChemexpress LLC
|
Mitapivat [CAS 1260075-17-9]
|
|
Cancer-Kinase/protease
|
|
HY-12689-100mg
|
MedChemexpress LLC
|
Mitapivat [CAS 1260075-17-9]
|
|
Cancer-Kinase/protease
|
|
HY-12689-5mg
|
MedChemexpress LLC
|
Mitapivat [CAS 1260075-17-9]
|
|
Cancer-Kinase/protease
|
|
HY-12689-50mg
|
MedChemexpress LLC
|
Mitapivat [CAS 1260075-17-9]
|
|
Cancer-Kinase/protease
|
|
HY-12689-1mL
|
MedChemexpress LLC
|
Mitapivat [CAS 1260075-17-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-12928-1mg
|
MedChemexpress LLC
|
ML336 [CAS 1613465-33-0]
|
|
COVID-19-anti-virus
|
|
HY-101850-25g
|
MedChemexpress LLC
|
MOPSO [CAS 68399-77-9]
|
|
|
|